These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17264401)

  • 1. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
    Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
    Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
    Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
    Suzuki S; Ishikawa K
    Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people.
    Tsai WC; Chao YC; Sheu LF; Lin YF; Nieh S; Chen A; Yu CP; Jin JS
    APMIS; 2007 Aug; 115(8):929-38. PubMed ID: 17696949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.
    Zheng HC; Wang W; Xu XY; Xia P; Yu M; Sugiyama T; Takano Y
    J Cancer Res Clin Oncol; 2011 Apr; 137(4):585-96. PubMed ID: 20514493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
    Tsai WC; Chao YC; Sheu LF; Chang JL; Nieh S; Jin JS
    Dis Markers; 2007; 23(3):153-60. PubMed ID: 17473384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
    Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
    Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
    Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
    Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters.
    Tsai WC; Chao YC; Lee WH; Chen A; Sheu LF; Jin JS
    Histopathology; 2006 Oct; 49(4):388-95. PubMed ID: 16978202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of EGFR and EMMPRIN in a series of cases of head and neck squamous cell carcinoma.
    de Andrade AL; Ferreira SJ; Ferreira SM; Ribeiro CM; Freitas Rde A; Galvão HC
    Pathol Res Pract; 2015 Oct; 211(10):776-81. PubMed ID: 26296920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas.
    Porebska I; Harlozińska A; Bojarowski T
    Tumour Biol; 2000; 21(2):105-15. PubMed ID: 10686540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters.
    Lee YY; Yu CP; Lin CK; Nieh S; Hsu KF; Chiang H; Jin JS
    Dis Markers; 2009; 26(1):9-18. PubMed ID: 19242064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
    Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
    Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
    Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
    Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
    Lawan AI; Ogunbiyi JO
    West Afr J Med; 2020; 37(2):100-105. PubMed ID: 32150626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
    Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.